Department of Surgery, University of Texas Southwestern Medical center, Dallas, Texas 75390-9160, USA.
Am J Physiol Heart Circ Physiol. 2012 May 1;302(9):H1847-59. doi: 10.1152/ajpheart.00203.2011. Epub 2012 Mar 9.
Using a mitochondria-targeted vitamin E (Mito-Vit-E) in a rat pneumonia-related sepsis model, we examined the role of mitochondrial reactive oxygen species in sepsis-mediated myocardial inflammation and subsequent cardiac contractile dysfunction. Sepsis was produced in adult male Sprague-Dawley rats via intratracheal injection of S. pneumonia (4 × 10(6) colony formation units per rat). A single dose of Mito-Vit-E, vitamin E, or control vehicle, at 21.5 μmol/kg, was administered 30 min postinoculation. Blood was collected, and heart tissue was harvested at various time points. Mito-Vit-E in vivo distribution was confirmed by mass spectrometry. In cardiac mitochondria, Mito-Vit-E improved total antioxidant capacity and suppressed H(2)O(2) generation, whereas vitamin E offered little effect. In cytosol, both antioxidants decreased H(2)O(2) levels, but only vitamin E strengthened antioxidant capacity. Mito-Vit-E protected mitochondrial structure and function in the heart during sepsis, demonstrated by reduction in lipid and protein oxidation, preservation of mitochondrial membrane integrity, and recovery of respiratory function. While both Mito-Vit-E and vitamin E suppressed sepsis-induced peripheral and myocardial production of proinflammatory cytokines (tumor necrosis factor-α, interleukin-1β, and interleukin-6), Mito-Vit-E exhibited significantly higher efficacy (P < 0.05). Stronger anti-inflammatory action of Mito-Vit-E was further shown by its near-complete inhibition of sepsis-induced myeloperoxidase accumulation in myocardium, suggesting its effect on neutrophil infiltration. Echocardiography analysis indicated that Mito-Vit-E ameliorated cardiac contractility of sepsis animals, shown by improved fractional shortening and ejection fraction. Together, our data suggest that targeted scavenging of mitochondrial reactive oxygen species protects mitochondrial function, attenuates tissue-level inflammation, and improves whole organ activities in the heart during sepsis.
在肺炎相关性脓毒症大鼠模型中使用靶向线粒体的维生素 E(Mito-Vit-E),我们研究了线粒体活性氧在脓毒症介导的心肌炎症及随后的心肌收缩功能障碍中的作用。通过气管内注射肺炎链球菌(每只大鼠 4×10(6)个菌落形成单位),在成年雄性 Sprague-Dawley 大鼠中产生脓毒症。接种后 30 分钟,给予 Mito-Vit-E、维生素 E 或对照载体单剂量 21.5μmol/kg。采集血液并在不同时间点采集心脏组织。通过质谱法证实了 Mito-Vit-E 的体内分布。在心肌线粒体中,Mito-Vit-E 提高了总抗氧化能力并抑制了 H(2)O(2)的产生,而维生素 E 几乎没有作用。在细胞质中,两种抗氧化剂均降低了 H(2)O(2)水平,但只有维生素 E 增强了抗氧化能力。Mito-Vit-E 在脓毒症期间保护心脏的线粒体结构和功能,表现为脂质和蛋白质氧化减少、线粒体膜完整性保持以及呼吸功能恢复。虽然 Mito-Vit-E 和维生素 E 均抑制了脓毒症引起的外周和心肌促炎细胞因子(肿瘤坏死因子-α、白细胞介素-1β 和白细胞介素-6)的产生,但 Mito-Vit-E 的效果明显更高(P<0.05)。Mito-Vit-E 的抗炎作用更强,因为它几乎完全抑制了脓毒症引起的心肌髓过氧化物酶积聚,表明其对中性粒细胞浸润的影响。超声心动图分析表明,Mito-Vit-E 改善了脓毒症动物的心脏收缩功能,表现为缩短分数和射血分数的改善。综上所述,我们的数据表明,靶向清除线粒体活性氧可保护线粒体功能,减轻组织水平的炎症,并改善脓毒症期间心脏的整体器官功能。